2 listed companies, Orion Pharma & Orion Infusion Limited discloses its financial reports for the second quarter, (October – December 23).
Orion Pharma: The company’s Consolidated earnings per share (EPS) Tk 0.47 paisa in Q2 of the current financial year (October – December 23). ConsolidatedEPS was Tk 1.19 paisa during the same period last year. Consolidated NAV per share was Tk. 89.69 (including revaluation) as of December 31, 2023.
Orion Infusion: The company’s earnings per share (EPS) Tk 0.41 paisa in Q2 of the current financial year (October – December 23). EPS was Tk 0.40 paisa during the same period last year. NAV per share was Tk. 14.53 as of December 31, 2023.
Share this
